Champions Oncolog
(CSBR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 07-2014 | 04-2014 | 01-2014 | 10-2013 | 07-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,548 | -7,406 | -5,134 | -4,556 | -2,232 |
| Depreciation Amortization | 56 | 213 | 158 | 102 | 50 |
| Accounts receivable | 400 | -825 | -2,623 | -962 | -1,284 |
| Accounts payable and accrued liabilities | 347 | -223 | -266 | -220 | -227 |
| Other Working Capital | 51 | -136 | -1,752 | -524 | -1,976 |
| Other Operating Activity | -94 | 4,944 | 6,059 | 4,258 | 3,525 |
| Operating Cash Flow | $-2,788 | $-3,433 | $-3,558 | $-1,902 | $-2,144 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -33 | -234 | -164 | -76 | -40 |
| Investing Cash Flow | $-33 | $-234 | $-164 | $-76 | $-40 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 0 | 21 | 0 | 9 | N/A |
| Financing Cash Flow | $0 | $21 | $N/A | $9 | $N/A |
| Exchange Rate Effect | -18 | -24 | -27 | -20 | -12 |
| Beginning Cash Position | 9,561 | 9,561 | 9,561 | 9,561 | 9,561 |
| End Cash Position | 6,722 | 5,891 | 5,812 | 7,572 | 7,365 |
| Net Cash Flow | $-2,839 | $-3,670 | $-3,749 | $-1,989 | $-2,196 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,788 | -3,433 | -3,558 | -1,902 | -2,144 |
| Capital Expenditure | -33 | -234 | -164 | -76 | -40 |
| Free Cash Flow | -2,821 | -3,667 | -3,722 | -1,978 | -2,184 |